Jan 25 (Reuters) - Adverum Biotechnologies Inc:
* ANNOUNCES EXTENSION OF ITS COLLABORATION AGREEMENT WITH EDITAS MEDICINE INC
* ADVERUM BIOTECHNOLOGIES - UNDER TERMS OF EXTENDED AGREEMENT, ADVERUM AND EDITAS ARE EXTENDING RESEARCH PERIOD THROUGH Q3 OF 2018
* SAYS EDITAS MAINTAINS A SERIES OF OPTIONS EXERCISABLE BETWEEN NOW AND AUGUST 2020 Source text for Eikon: Further company coverage:
 